CXCR4 and neoplasm: Of note, elevated CXCL12 production by RI-treated dying cells agreed with the increased expression of CXCR4 on IFN-DCs, a receptor known to guide mature DC motility56, thus contributing to IFN-DC migration toward RI tumor space.